A urine culture test grows bacteria from a urine sample to identify the specific organism causing a urinary tract infection (UTI), plus tests which antibiotics will work against it. It is also called urine C&S (culture and sensitivity), urine MC&S (microscopy, culture and sensitivity), or aerobic urine culture. Results take 24 to 48 hours.
Medically reviewed by Dr. Qiao Yufei, MD
This guide explains what a urine culture is, how it differs from urine FEME (urinalysis), the bacteria most commonly identified, what colony count thresholds mean, and how antibiotic sensitivity testing guides treatment. Available at Mediway Medical Centre with same-day sample collection and lab turnaround within 1 to 2 days.
A urine culture is a laboratory test that grows bacteria from a urine sample on agar plates so the lab can identify the specific organism and test it against a panel of antibiotics. Unlike urine FEME (urinalysis), which screens for markers of infection in minutes, urine culture provides the definitive answer about which bacterium is causing a UTI and which antibiotics will treat it.
The test is sometimes labelled urine C&S (culture and sensitivity) or urine MC&S (microscopy, culture and sensitivity). All these terms describe the same workflow: streak the sample onto agar, incubate, identify any bacterial growth, and run antibiotic susceptibility testing.
Urine culture grows the bacteria; FEME just detects markers. A culture identifies the specific organism (E. coli, Klebsiella, Proteus, etc.) and tells your doctor which antibiotic will work. Results in 24 to 48 hours.
The two tests are complementary, not interchangeable. They are often ordered together when UTI is suspected.
For a typical UTI presentation: FEME gives a fast preliminary answer (treat empirically if leukocytes + nitrites are positive), and a urine culture is sent in parallel to confirm the organism and refine antibiotic choice if needed.
Urine culture is more selective than FEME. Common indications:
Urine culture results are reported as colony forming units per millilitre (CFU/mL): a measure of how many bacterial colonies grew from the sample. The threshold for "significant bacteriuria" depends on the patient and sample type:
| Sample / patient | Threshold for significant bacteriuria |
|---|---|
| Symptomatic woman, clean-catch midstream | ≥ 105 CFU/mL of a single uropathogen (the classic threshold) |
| Symptomatic woman with cystitis (acute) | ≥ 103 CFU/mL may be significant if symptoms are typical |
| Symptomatic man | ≥ 104 CFU/mL (lower threshold because contamination is less common in men) |
| Catheterised sample | ≥ 102–103 CFU/mL (depends on guideline; lower because catheterisation reduces contamination) |
| Suprapubic aspirate | Any growth is significant (sterile sampling method) |
| Asymptomatic bacteriuria in pregnancy | ≥ 105 CFU/mL on two consecutive cultures |
| Mixed bacterial growth at low counts | Usually contamination; consider repeat with proper clean-catch |
Your doctor interprets the count alongside your symptoms, FEME findings, and any prior antibiotic exposure. A "positive" culture without symptoms (asymptomatic bacteriuria) is generally not treated outside of pregnancy, because antibiotics increase resistance and disrupt urinary flora without clinical benefit.
Most uncomplicated UTIs are caused by a small set of bacteria. Approximate frequency in community-acquired UTI:
The dominant uropathogen. Lives in the gut and ascends to the bladder via the urethra. Most strains susceptible to first-line antibiotics, but resistance is rising.
Second most common. May produce extended-spectrum beta-lactamases (ESBLs), which require alternative antibiotics. More common in healthcare-associated UTI.
Produces urease, which raises urine pH and predisposes to struvite kidney stones. Often associated with chronic catheterisation.
Common in young, sexually active women (sometimes called "honeymoon cystitis"). Coagulase-negative staphylococcus, distinct from S. aureus.
Common in older patients, post-instrumentation, or after broad-spectrum antibiotics. May be vancomycin-resistant (VRE) in healthcare settings.
Less common in community UTI; more frequent in catheter-associated, post-instrumentation, or hospital settings. Often multi-drug resistant.
Particularly relevant in pregnancy: GBS in urine indicates heavy genital colonisation and warrants intrapartum antibiotic prophylaxis.
"No growth" rules out bacterial UTI. "Mixed bacterial growth" at low counts usually means contamination from skin or genital flora; repeat with proper clean-catch.
Once the lab identifies the specific bacterium, it tests the organism against a panel of antibiotics to determine which will work. Each antibiotic is reported as one of three categories:
Your doctor uses the sensitivity panel to choose the most effective antibiotic that is appropriate for your symptoms, allergies, and the local resistance patterns. Empirical antibiotics started before the culture result are adjusted to match the sensitivity report when it returns.
Antibiotic resistance in urinary pathogens is rising globally and in Singapore. Up to 20 to 30% of community E. coli is resistant to trimethoprim-sulfamethoxazole or amoxicillin in some regions. Sensitivity testing prevents treatment failure and avoids unnecessary antibiotic exposure that drives further resistance.
The standard urine culture sample is a clean-catch midstream specimen. Proper technique is essential because contamination is the most common cause of misleading results:
A preliminary culture report is typically available at 24 hours; the final report (with full sensitivity panel) at 48 hours. Empirical antibiotic treatment can usually start before the result is back if symptoms warrant; the regimen is then adjusted based on sensitivity.
Urine culture is offered at Mediway Medical Centre for confirmed or suspected UTI, recurrent infection, pregnancy screening, and treatment-failure cases. We typically order it alongside urine FEME as a paired workup:
Contact us for current pricing and to arrange a slot. WhatsApp is the fastest way: 8779 9898.
A urine culture test grows bacteria from a urine sample to identify the specific organism causing a urinary tract infection (UTI), plus tests which antibiotics will work against it (antibiotic sensitivity testing). It is also called urine C&S (culture and sensitivity), urine MC&S (microscopy, culture and sensitivity), or aerobic urine culture. Results take 24 to 48 hours.
Urine FEME (urinalysis) is a fast screening test (minutes to hours) that detects markers of infection (leukocytes, nitrites) and other findings (protein, blood, glucose). Urine culture is a slower confirmatory test (24 to 48 hours) that grows and identifies the specific bacterium plus tests antibiotic sensitivity. FEME suggests UTI; culture confirms it and guides treatment.
Bacteria in urine on culture means the lab grew at least one bacterial colony from the sample. Whether this represents real infection (significant bacteriuria) or contamination depends on the colony count: ≥100,000 CFU/mL of a single organism in a clean-catch midstream sample from a symptomatic woman is considered significant. Lower thresholds apply to symptomatic men, catheterised samples, or pregnancy. Mixed bacterial growth at low counts often indicates contamination.
The most common UTI organism is Escherichia coli (E. coli), responsible for around 75 to 90% of uncomplicated UTIs. Other common organisms include Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus saprophyticus (especially in young women), Enterococcus species, and Pseudomonas aeruginosa (more common in catheterised or hospital patients). Group B Streptococcus can also colonise the urinary tract, particularly in pregnancy.
Standard urine cultures take 24 to 48 hours: bacteria are streaked onto agar plates and incubated, then identified and tested for antibiotic sensitivity. Some labs report a preliminary result at 24 hours and a final result at 48 to 72 hours. Empirical antibiotic treatment can usually start before the culture result is back, then be adjusted once the sensitivity report arrives.
Antibiotic sensitivity testing (also called susceptibility testing) determines which antibiotics will kill the specific bacterium found in the culture. The lab tests the bacterium against a panel of antibiotics and reports each as Sensitive (S), Intermediate (I), or Resistant (R). Doctors use this to choose the most effective antibiotic. This is particularly important in recurrent UTIs, treatment-failure cases, and infections with multi-drug-resistant organisms.
For confirmed or suspected UTI in symptomatic patients (especially with positive FEME), recurrent UTI (more than 2 in 6 months or 3 in 12 months), pregnancy (asymptomatic bacteriuria screening), pyelonephritis, treatment failure with empirical antibiotics, complicated UTI in men or with structural urinary tract abnormalities, hospital-acquired or catheter-associated UTI, and post-procedure infections.
References: CDC: Urinary tract infections · HealthHub Singapore
This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional for interpretation of urine culture results and treatment decisions.